The global medical marijuana market is experiencing unprecedented growth, with projections indicating a surge towards and beyond $130 billion as worldwide demand accelerates. This expansion is fueled by evolving legal frameworks, increasing patient access, and a growing acceptance of cannabis-based therapies for a range of medical conditions. Key Highlights: Global medical marijuana market projected to…
The landscape of medical cannabis is rapidly evolving, necessitating enhanced clinical understanding among healthcare professionals. In response to this growing need, particularly with recent discussions around federal rescheduling, TheAnswerPage.com has launched a comprehensive Continuing Medical Education (CME) and Continuing Education (CE) course. This initiative aims to equip clinicians with the latest evidence-based information, best practices,…
As the United States continues its steady march toward broader cannabis acceptance, a pivotal new report released today, May 1, 2026, casts a sobering light on the intersection of legislative progress and systemic inequality. Published in the American Economic Journal: Economic Policy by researchers from Weill Cornell Medicine, the University of Texas at Austin, and…
As of April 2026, the future of the Texas hemp industry hangs in the balance within the confines of a Travis County courtroom. The Texas Hemp Business Council (THBC), alongside a coalition of manufacturers and retailers, has launched a significant legal challenge against the Texas Department of State Health Services (DSHS) and the Texas Health…
Herbal Dispatch Inc. (CSE: HERB) has officially entered the competitive edibles landscape with the launch of its first dedicated brand, Chomp Edibles. This strategic move marks a pivot in the company’s operational roadmap, leveraging its established e-commerce platform to capture a larger share of the rapidly maturing Canadian cannabis market. By introducing a brand specifically…
In a decisive move that marks the most significant alteration in federal drug policy since the 1970s, the Trump administration has officially reclassified state-licensed medical marijuana and FDA-approved cannabis products from Schedule I to Schedule III under the Controlled Substances Act. This action, spearheaded by Acting Attorney General Todd Blanche, delivers on the directives outlined…
The landscape of federal drug policy in the United States reached a potential inflection point this week when House Minority Leader Hakeem Jeffries (D-NY) declared that the votes required to pass significant federal cannabis reform already exist within the chamber. Speaking on the unofficial cannabis holiday of April 20, Jeffries emphasized that the only barrier…
New research published today in the journal Neuropsychopharmacology has provided perhaps the most robust evidence to date regarding the impact of cannabis on the developing adolescent brain. The study, which analyzed data from more than 11,000 participants in the National Institutes of Health’s (NIH) Adolescent Brain Cognitive Development (ABCD) Study, found a clear correlation between…
Planet 13 Holdings has officially launched its new Dreamland Chocolate line across its Florida dispensary network as of April 17, 2026. This move introduces a sophisticated suite of cannabinoid-infused confections to the state’s medical cannabis market, specifically highlighting a 1:1:1 THC:CBD:CBN formulation. By focusing on balanced, ratio-driven products rather than simple THC potency, Planet 13…
The Missouri Department of Health and Senior Services (DHSS) has officially initiated a pivotal step in the state’s cannabis evolution, filing proposed rules to establish dedicated marijuana research facilities. This development, outlined in the recently introduced 19 CSR 100-1.200, signals a move beyond mere retail and cultivation, aiming to cement Missouri’s position as a hub…
